70 related articles for article (PubMed ID: 23489277)
21. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.
Friedrich MG; Chandrasoma S; Siegmund KD; Weisenberger DJ; Cheng JC; Toma MI; Huland H; Jones PA; Liang G
Eur J Cancer; 2005 Nov; 41(17):2769-78. PubMed ID: 16242928
[TBL] [Abstract][Full Text] [Related]
23. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
25. [Assay of methylated gene RARbeta2 in circulating DNA of blood from patients with lung cancer as a potential prognostic marker].
Ponomareva AA; Rykova EIu; Cherdyntseva NV; Skvortsova TE; Dobrodeev AIu; Litviakov NV; Zav'ialov AA; Tuzikov SA; Vlasov VV; Laktionov PP
Vopr Onkol; 2011; 57(3):302-7. PubMed ID: 21882599
[TBL] [Abstract][Full Text] [Related]
26. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
27. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients.
Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM
Clin Cancer Res; 2008 Jul; 14(13):4141-5. PubMed ID: 18593992
[TBL] [Abstract][Full Text] [Related]
28. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation analysis: a powerful new tool for lung cancer diagnosis.
Tsou JA; Hagen JA; Carpenter CL; Laird-Offringa IA
Oncogene; 2002 Aug; 21(35):5450-61. PubMed ID: 12154407
[TBL] [Abstract][Full Text] [Related]
30. A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.
Müller HM; Widschwendter A; Fiegl H; Goebel G; Wiedemair A; Müller-Holzner E; Marth C; Widschwendter M
Cancer Lett; 2004 Jun; 209(2):231-6. PubMed ID: 15159026
[TBL] [Abstract][Full Text] [Related]
31. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
33. DNA-based assay for EPHB6 expression in breast carcinoma cells as a potential diagnostic test for detecting tumor cells in circulation.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2010; 7(1):9-16. PubMed ID: 20181626
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
[TBL] [Abstract][Full Text] [Related]
35. RARβ2 gene methylation level in the circulating DNA from blood of patients with lung cancer.
Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Tuzikov SA; Vlassov VV; Laktionov PP
Eur J Cancer Prev; 2011 Nov; 20(6):453-5. PubMed ID: 21795979
[TBL] [Abstract][Full Text] [Related]
36. Recovering circulating extracellular or cell-free RNA from bodily fluids.
Tzimagiorgis G; Michailidou EZ; Kritis A; Markopoulos AK; Kouidou S
Cancer Epidemiol; 2011 Dec; 35(6):580-9. PubMed ID: 21514265
[TBL] [Abstract][Full Text] [Related]
37. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.
González-Quevedo R; García-Aranda C; Morán A; De Juan C; Sánchez-Pernaute A; Torres A; Díaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Int J Oncol; 2004 Feb; 24(2):349-55. PubMed ID: 14719111
[TBL] [Abstract][Full Text] [Related]
38. MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.
Ling ZQ; Zhao Q; Zhou SL; Mao WM
Eur J Surg Oncol; 2012 Apr; 38(4):326-32. PubMed ID: 22265839
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
40. Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
Christoph F; Hinz S; Weikert S; Kempkensteffen C; Schostak M; Miller K; Schrader M
Urol Int; 2008; 80(4):398-404. PubMed ID: 18587251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
